Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -680 | -2,202 | -2,012 | -1,826 | -1,302 |
| Depreciation Amortization | 637 | 2,119 | 1,471 | 870 | 367 |
| Accounts receivable | -576 | -108 | -346 | -262 | -636 |
| Accounts payable and accrued liabilities | -76 | 1,691 | 2,201 | 1,412 | 664 |
| Other Working Capital | -888 | 1,918 | 2,142 | 1,875 | 177 |
| Other Operating Activity | 841 | -801 | -1,248 | -752 | 172 |
| Operating Cash Flow | $-741 | $2,617 | $2,207 | $1,316 | $-558 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -313 | -4,936 | -4,268 | -3,005 | -1,599 |
| Investing Cash Flow | $-313 | $-4,936 | $-4,268 | $-3,005 | $-1,599 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 365 | 3,970 | 3,970 | 3,970 | N/A |
| Common Stock Repurchased | N/A | -65 | -65 | -65 | N/A |
| Dividend Paid | -142 | -77 | -58 | -39 | -19 |
| Financing Cash Flow | $223 | $3,828 | $3,847 | $3,866 | $-19 |
| Beginning Cash Position | 5,177 | 3,669 | 3,669 | 3,669 | 3,669 |
| End Cash Position | 4,346 | 5,177 | 5,454 | 5,846 | 1,492 |
| Net Cash Flow | $-831 | $1,509 | $1,786 | $2,177 | $-2,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -741 | 2,617 | 2,207 | 1,316 | -558 |
| Capital Expenditure | -313 | -4,936 | -4,268 | -3,005 | -1,599 |
| Free Cash Flow | -1,053 | -2,319 | -2,061 | -1,689 | -2,157 |